We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
201
DELISTED
Arcellx
ACLX
$15.3M 0.1%
220,008
-62,005
-22% -$3.93M
NLY icon
202
Annaly Capital Management
NLY
$17.4B
$15.2M 0.1%
770,504
+369,730
+92% +$7.13M
IRM icon
203
Iron Mountain
IRM
$37.4B
$15.1M 0.1%
188,448
+144,529
+329% +$10.5M
ASND icon
204
Ascendis Pharma A/S
ASND
$16.7B
$15M 0.1%
99,375
– –
ARGX icon
205
argenx
ARGX
$54.6B
$15M 0.1%
+38,153
New +$14.8M
VCYT icon
206
Veracyte
VCYT
$4.44B
$14.9M 0.1%
670,937
+60,005
+10% +$1.46M
MCO icon
207
Moody's
MCO
$83.9B
$14.8M 0.09%
37,705
+14,908
+65% +$5.75M
BNTX icon
208
BioNTech
BNTX
$23.4B
$14.8M 0.09%
160,303
+120,000
+298% +$11.5M
TNET icon
209
TriNet
TNET
$3.14B
$14.4M 0.09%
108,843
+10,104
+10% +$1.23M
XNCR icon
210
Xencor
XNCR
$1.48B
$14.4M 0.09%
651,317
-56,667
-8% -$1.22M
IEX icon
211
IDEX
IEX
$16.6B
$14.3M 0.09%
58,640
+8,374
+17% +$1.89M
TGT icon
212
Target
TGT
$65.5B
$14.2M 0.09%
80,261
+19,774
+33% +$3.01M
KURA icon
213
Kura Oncology
KURA
$826M
$13.9M 0.09%
651,417
+110,000
+20% +$2.14M
JBL icon
214
Jabil
JBL
$31.7B
$13.8M 0.09%
103,312
-47,511
-32% -$6.38M
IDXX icon
215
Idexx Laboratories
IDXX
$44.9B
$13.8M 0.09%
25,538
-9,098
-26% -$4.97M
MTB icon
216
M&T Bank
MTB
$36.6B
$13.7M 0.09%
93,943
+7,989
+9% +$1.11M
EBAY icon
217
eBay
EBAY
$52.1B
$13.6M 0.09%
257,492
-154,857
-38% -$7.04M
EXAS
218
DELISTED
Exact Sciences
EXAS
$13.6M 0.09%
196,753
-81,917
-29% -$5.18M
BZ icon
219
Kanzhun
BZ
$7.07B
$13.4M 0.09%
767,000
-1,390,254
-64% -$21.9M
CLDX icon
220
Celldex Therapeutics
CLDX
$2.79B
$13.3M 0.09%
317,509
– –
KYMR icon
221
Kymera Therapeutics
KYMR
$8.73B
$13.2M 0.08%
328,302
-15,000
-4% -$537K
KMX icon
222
CarMax
KMX
$8.36B
$13.2M 0.08%
151,169
+17,651
+13% +$1.34M
NRIX icon
223
Nurix Therapeutics
NRIX
$2.51B
$13.1M 0.08%
892,110
-26,000
-3% -$280K
AMRC icon
224
Ameresco
AMRC
$1.04B
$13M 0.08%
538,027
+16
+0% +$359
MRSH
225
Marsh
MRSH
$91.7B
$12.8M 0.08%
59,555
+3,524
+6% +$702K
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.